FDA could set record low for drug marketing warning letters — again - BioPharma Dive

FDA could set record low for drug marketing warning letters — again - BioPharma Dive | marketing - Google News | October 03, 2018 at 02:34PM

FDA could set record low for drug marketing warning letters — again BioPharma Dive Julie Tibbets, a partner in the technology and life sciences group at the law firm Goodwin Procter, explained the FDA seems more focused on writing guidance than letters, which could lead some marketing and legal teams to adjust their risk tolerance ...

October 03, 2018 at 02:34PM | marketing - Google News
FDA could set record low for drug marketing warning letters — again - BioPharma Dive
marketing - Google News